Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 552,971 | 452,166 | 319,545 | 407,179 | 366,366 |
| Gross Profit | 552,971 | 452,166 | 319,545 | 407,179 | 366,366 |
| Operating Expenses | 291,707 | 273,845 | 242,034 | 281,979 | 225,212 |
| Operating Income | 261,264 | 178,321 | 77,511 | 125,200 | 141,154 |
| Interest Expense | 28,684 | 28,600 | 51,121 | -6,812 | 36,478 |
| Other Income | 210,121 | 206,206 | 65,900 | 16,726 | 81,045 |
| Pre-tax Income | 442,702 | 355,927 | 92,290 | 148,738 | 185,721 |
| Income Tax | 93,357 | 85,514 | 22,168 | 38,584 | 44,567 |
| Net Income Continuous | 349,345 | 270,413 | 70,122 | 110,155 | 141,154 |
| Net Income | $349,345 | $270,413 | $70,122 | $110,155 | $141,154 |
| EPS Basic Total Ops | 5.35 | 4.13 | 1.07 | 3.63 | 0.22 |
| EPS Basic Continuous Ops | 5.35 | 4.13 | 1.07 | 3.63 | 0.22 |
| EPS Diluted Total Ops | 5.30 | 4.10 | 1.06 | 3.59 | 0.21 |
| EPS Diluted Continuous Ops | 5.30 | 4.10 | 1.06 | 3.59 | 0.21 |
| EBITDA(a) | $261,264 | $178,321 | $77,511 | $125,200 | $141,154 |